Editas Medicine

A series of dice with a bag on them illustrating cost cuts
Biotech

Editas lays off 65% after fruitless search for reni-cel partner

Editas is laying off three-quarters of its workforce after the gene editing biotech was unable to find a partner for its sickle cell disease med.
James Waldron Dec 13, 2024 4:44am
An artists concept of gene editing A DNA strand appears in blue with edited regions in red

Editas prioritizes in vivo therapies, seeks reni-cel partner

Oct 22, 2024 9:39am
gene edits scientists gene editing CRISPR

Editas cashes in on Vertex Cas9 licensing agreement for $57M

Oct 4, 2024 5:06am
new hire welcome leadership people gap bridge

How Editas 'dragged' new CSO over after 37 years at Biogen

May 10, 2024 11:08am
San Francisco night skyline

JPM24, Day 3: Gene editors talk BD; Roivant has cash to spend

Jan 10, 2024 4:38pm
gene edits scientists gene editing CRISPR

Vertex pays Editas $100M to use gene-editing tech

Dec 13, 2023 12:46pm